Sansheng Guojian: Announcement of Resolutions of the First Meeting of the Fifth Board of Supervisors
Sansei Guojian: Announcement on holding the 2024 semi-annual results briefing
Sansei Guojian: Investor Relations Activity Record List (August 23-26, 2024)
Sunshine Guojian Pharmaceutical: Announcement of Resolutions of the Twentieth Meeting of the Fourth Supervisory Board.
Sunshine Guojian Pharmaceutical: Special report on the use and deposit of funds raised in the first half of 2024 for the company.
Sunshine Guojian Pharmaceutical: Semi-annual evaluation report on the 'Quality Improvement and Efficiency Enhancement for Return' action plan for the company's 2024 fiscal year.
Sunshine Guojian Pharmaceutical: Announcement regarding the continuing use of temporarily idle funds raised for cash management.
China Merchants Securities Co., Ltd.'s verification opinion on Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.'s continued use of a portion of temporarily idle raised funds for cash management.
Sunshine Guojian Pharmaceutical: Statement and Commitment of the Nominee Independent Director (Zhang Wei)
Sunshine Guojian Pharmaceutical: Statement and Commitment of Independent Director Nominee (You Song)
Sunshine Guojian Pharmaceutical: Statement and Commitment of Independent Director Nominee (Jin Yongli)
Sunshine Guojian Pharmaceutical: The Nomination Committee of the Fourth Board of Directors on the review opinions of the independent director candidates of the Fifth Board of Directors.
Sunshine Guojian Pharmaceutical: Statement and Commitment of Independent Director Candidate (Zhang Wei)
Sunshine Guojian Pharmaceutical: Independent Director Candidate Statement and Commitment (You Song)
Sunshine Guojian Pharmaceutical: Statement and Commitment of Independent Director Candidates (Jin Yongli)
Sunshine Guojian Pharmaceutical: Announcement of Resolutions of the Nineteenth Meeting of the Fourth Supervisory Committee.
Sunshine Guojian Pharmaceutical: Announcement of the Resolutions of the 25th Meeting of the 4th Board of Directors.
China Tai United Securities Co., Ltd.'s verification opinion on the initial public offering of restricted shares of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sunshine Guojian Pharmaceutical: Assessment and management method for the implementation of restricted stock incentive plan in 2024.
Sunshine Guojian Pharmaceutical: Announcement Regarding Signing of Licensing Agreement and Related Trade with 3sbio of Shenyang.
No Data
No Data